Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Organics Corporation of America DBA Ambix Laboratories
WARNING LETTER
•Organics Corporation of America DBA Ambix Laboratories•May 7, 2012

Organics Corporation of America DBA Ambix Laboratories – FDA Warning Letter, May 7, 2012

Record Details

The FDA inspected Organics Corporation of America (DBA Ambix Laboratories) in Totowa, NJ, from April 9 to May 7, 2012, and found serious violations of dietary supplement CGMP regulations (21 CFR Part 111). This renders their Baby Plex Vitamin Drops, Carnitine Liquid, and Optimal Nutritional Liquid products adulterated.

Key violations include: 1. **Failure to verify finished batch specifications (21 CFR 111.75(c)):** The firm manufactured numerous batches of the listed products since 2010 without testing to verify identity, purity, strength, composition, or contamination limits. Their proposed corrective action lacked a sound statistical plan for subset testing and did not address purity, strength, or contamination. 2. **Failure to verify component identity and specifications (21 CFR 111.75(a)(1)(i), 111.75(a)(2)):** The firm did not conduct appropriate tests to verify the identity of dietary ingredients or confirm specifications for other components in Baby Plex Vitamin Drops, Optimal Nutrition Liquid, and Carnitine Liquid. Their response lacked "current Ambix specification" documentation and supporting evidence for retesting raw materials. 3. **Failure to maintain equipment logs (21 CFR 111.35(b)(2)):** The firm did not keep records of cleaning and sanitizing equipment used

Company
Organics Corporation of America DBA Ambix Laboratories
Inspection date
May 7, 2012
Product type
Food
Office
New Jersey District Office
Person
  • Diana Amador-Toro (District Director)
View Company Profile

ID · 67b12729-944c-494a-bc78-0cf999025e91

Violation Codes9
21 CFR 111.75(c)21 U.S.C. 342(g)(1)21 CFR 111.75(a)(1)(i)21 CFR 111.70(b)21 CFR 111.75(a)(2)21 CFR 111.35(b)(2)21 CFR 111.80(a)21 CFR 111.455(a)21 U.S.C. 379j-31

Full citation text and observation details available on the Dashboard.

Other documents for Organics Corporation of America DBA Ambix Laboratories
  • 483 - 2014-08-22August 22, 2014
  • 483 - 2014-02-24February 24, 2014
  • 483 - 2012-05-07May 7, 2012

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Organics Corporation of America DBA Ambix Laboratories
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.